Mirae Asset Global Investments Co., Ltd. Travere Therapeutics, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $24 Billion
- Q4 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 2,861 shares of TVTX stock, worth $57,849. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,861
Previous 2,767
3.4%
Holding current value
$57,849
Previous $38,000
28.95%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding TVTX
# of Institutions
198Shares Held
84.9MCall Options Held
776KPut Options Held
912K-
Armistice Capital, LLC New York, NY7.65MShares$155 Million1.78% of portfolio
-
Black Rock Inc. New York, NY7.64MShares$155 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.9MShares$140 Million0.0% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD4.68MShares$94.7 Million2.23% of portfolio
-
Woodline Partners LP San Francisco, CA4.34MShares$87.8 Million0.55% of portfolio
About Travere Therapeutics, Inc.
- Ticker TVTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,173,600
- Market Cap $1.3B
- Description
- Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...